Skip Navigation
Past Events by Category

Inactivated Virions; Used as Immunogens in Vaccines and as in Vitro Reagents HHS Only

Tuesday, June 5, 2001

Larry Arthur PH.D.
Category: HHS Only

Read more *83 views - Runtime: 00:52:25
Development and Testing of Vaccines for Genital Herpes HHS Only

Tuesday, May 29, 2001

Stephen E. Straus, M.D.
Category: HHS Only

Read more *86 views - Runtime: 01:16:26
Approaches to Design Improved Engineered Vaccines for HIV HHS Only

Tuesday, May 22, 2001

Jay Berzofsky, M.D. NCI
Category: HHS Only

Read more *85 views - Runtime: 01:17:21
Immune Evasion by HIV-1 HHS Only

Tuesday, May 15, 2001

Joseph Sodroski, M.D. Department of Pathology, Harvard
Category: HHS Only

Read more *85 views - Runtime: 01:11:59
Comparative Trials of New Vaccines: What Happens After the Initial Results? HHS Only

Tuesday, May 8, 2001

Dr. Larry Corey
Category: HHS Only

Read more *85 views - Runtime: 01:18:37
Host Factors in HIV Disease: Implications for Therapeutic Strategies (NIH-Only) HHS Only

Tuesday, April 24, 2001

Anthony Fauci, M.D. NIAID
Category: HHS Only

Read more *84 views - Runtime: 01:03:55
Studies on HIV-1 Envelope Glycoprotein Vaccine Antigens and Entry Inhibitors HHS Only

Tuesday, April 17, 2001

John Moore, Ph.D. Cornell University
Category: HHS Only

Read more *85 views - Runtime: 01:16:13
Form and Function of Anti-Viral Beta-Chemokines Synthesized by Diverse T Cell Subsets HHS Only

Tuesday, April 10, 2001

George Lewis, PH.D., Institute of Human Virology
Category: HHS Only

Read more *83 views - Runtime: 00:58:58
The Use of Highly Pathogenic SIV/HIV Chimeric Viruses for Studies of Immunodeficiency HHS Only

Tuesday, March 20, 2001

Malcolm Martin, M.D. Molecular Microbiology, NIAID
Category: HHS Only

Read more *86 views - Runtime: 01:12:41
Role of HIV-1 envelope glycoproteins in neurotropism and viral pathogenesis HHS Only

Tuesday, March 13, 2001

Dana H. Gabuzda, M.D., Dana-Farber Cancer Institute
Category: HHS Only

Read more *86 views - Runtime: 01:05:46